Study of Neoadjuvant RBP-01 In Patients With Primary Uveal Melanoma
NCT07747935
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
NOT_YET_RECRUITING
Status
30
Enrollment
INDUSTRY
Sponsor class
Conditions
Uveal Melanoma
Interventions
DRUG:
RBP-01
Sponsor
ReBio Pharma